SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: T Pat who wrote (924)5/16/1999 10:11:00 PM
From: Investor Dave  Read Replies (1) of 998
 
Don't blame you for getting out. It takes the patience of a saint to stay in biotech stocks right now. I'm going to hold on a little longer. I think Provigil is a drug that works and sales will pick up. They also should receive FDA approval for their (which they are partnering with Chiron) ALS drug Myotrophin soon. This is just one of those stocks you have to hold for 2 to 3 years for some action. With all the new FDA drug approvals coming from these biotech companies, wall street will need to take notice soon. More and more of these companies should become profitable in the next two years.

One consolation to holding on to Ceph at this time is that wall street is allowing these stocks to go for just about nothing right now.

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext